0001308027 false 2022 Q3 --12-31 Yes Yes 0001308027 2022-01-01 2022-09-30 0001308027 2022-12-06 0001308027 2022-09-30 0001308027 2021-12-31 0001308027 us-gaap:SeriesAPreferredStockMember 2022-09-30 0001308027 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001308027 us-gaap:SeriesBPreferredStockMember 2022-09-30 0001308027 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001308027 us-gaap:SeriesCPreferredStockMember 2022-09-30 0001308027 us-gaap:SeriesCPreferredStockMember 2021-12-31 0001308027 2022-07-01 2022-09-30 0001308027 2021-07-01 2021-09-30 0001308027 2021-01-01 2021-09-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-12-31 0001308027 us-gaap:CommonStockMember 2021-12-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001308027 us-gaap:RetainedEarningsMember 2021-12-31 0001308027 us-gaap:TreasuryStockMember 2021-12-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2021-12-31 0001308027 us-gaap:NoncontrollingInterestMember 2021-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-03-31 0001308027 us-gaap:CommonStockMember 2022-03-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001308027 us-gaap:RetainedEarningsMember 2022-03-31 0001308027 us-gaap:TreasuryStockMember 2022-03-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-03-31 0001308027 us-gaap:NoncontrollingInterestMember 2022-03-31 0001308027 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-06-30 0001308027 us-gaap:CommonStockMember 2022-06-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001308027 us-gaap:RetainedEarningsMember 2022-06-30 0001308027 us-gaap:TreasuryStockMember 2022-06-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-06-30 0001308027 us-gaap:NoncontrollingInterestMember 2022-06-30 0001308027 2022-06-30 0001308027 us-gaap:PreferredStockMember 2020-12-31 0001308027 us-gaap:CommonStockMember 2020-12-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001308027 us-gaap:RetainedEarningsMember 2020-12-31 0001308027 us-gaap:TreasuryStockMember 2020-12-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2020-12-31 0001308027 us-gaap:NoncontrollingInterestMember 2020-12-31 0001308027 2020-12-31 0001308027 us-gaap:PreferredStockMember 2021-03-31 0001308027 us-gaap:CommonStockMember 2021-03-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001308027 us-gaap:RetainedEarningsMember 2021-03-31 0001308027 us-gaap:TreasuryStockMember 2021-03-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2021-03-31 0001308027 us-gaap:NoncontrollingInterestMember 2021-03-31 0001308027 2021-03-31 0001308027 us-gaap:PreferredStockMember 2021-06-30 0001308027 us-gaap:CommonStockMember 2021-06-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001308027 us-gaap:RetainedEarningsMember 2021-06-30 0001308027 us-gaap:TreasuryStockMember 2021-06-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2021-06-30 0001308027 us-gaap:NoncontrollingInterestMember 2021-06-30 0001308027 2021-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-03-31 0001308027 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001308027 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001308027 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-01-01 2022-03-31 0001308027 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001308027 2022-01-01 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-04-01 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-04-01 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-04-01 2022-06-30 0001308027 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001308027 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001308027 us-gaap:TreasuryStockMember 2022-04-01 2022-06-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-04-01 2022-06-30 0001308027 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001308027 2022-04-01 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-07-01 2022-09-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-07-01 2022-09-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-07-01 2022-09-30 0001308027 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001308027 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001308027 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-07-01 2022-09-30 0001308027 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001308027 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001308027 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001308027 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001308027 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2021-01-01 2021-03-31 0001308027 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001308027 2021-01-01 2021-03-31 0001308027 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001308027 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001308027 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001308027 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2021-04-01 2021-06-30 0001308027 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001308027 2021-04-01 2021-06-30 0001308027 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001308027 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001308027 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001308027 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2021-07-01 2021-09-30 0001308027 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-09-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-09-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-09-30 0001308027 us-gaap:CommonStockMember 2022-09-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001308027 us-gaap:RetainedEarningsMember 2022-09-30 0001308027 us-gaap:TreasuryStockMember 2022-09-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-09-30 0001308027 us-gaap:NoncontrollingInterestMember 2022-09-30 0001308027 us-gaap:PreferredStockMember 2021-09-30 0001308027 us-gaap:CommonStockMember 2021-09-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001308027 us-gaap:RetainedEarningsMember 2021-09-30 0001308027 us-gaap:TreasuryStockMember 2021-09-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2021-09-30 0001308027 us-gaap:NoncontrollingInterestMember 2021-09-30 0001308027 2021-09-30 0001308027 us-gaap:CommonStockMember 2022-08-28 2022-09-01 0001308027 2022-08-28 2022-09-01 0001308027 us-gaap:PreferredStockMember 2022-08-28 2022-09-01 0001308027 VYST:StevenRotmanMember 2022-09-30 0001308027 VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:StevenRotmanMember 2022-01-01 2022-09-30 0001308027 srt:MinimumMember 2022-01-01 2022-09-30 0001308027 srt:MaximumMember 2022-01-01 2022-09-30 0001308027 VYST:PatentMember srt:MinimumMember 2022-01-01 2022-09-30 0001308027 srt:MaximumMember VYST:PatentMember 2022-01-01 2022-09-30 0001308027 VYST:OptionsToPurchaseCommonSharesMember 2022-01-01 2022-09-30 0001308027 VYST:OptionsToPurchaseCommonSharesMember 2021-01-01 2021-09-30 0001308027 VYST:WarrantsToPurchaseCommonSharesMember 2022-01-01 2022-09-30 0001308027 VYST:WarrantsToPurchaseCommonSharesMember 2021-01-01 2021-09-30 0001308027 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001308027 us-gaap:ConvertiblePreferredStockMember 2021-01-01 2021-09-30 0001308027 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-09-30 0001308027 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-09-30 0001308027 VYST:ShareholderAndRotmanFamilyMember 2022-09-30 0001308027 VYST:ShareholderAndRotmanFamilyMember 2021-09-30 0001308027 2021-01-01 2021-12-31 0001308027 VYST:DeferredWarrantyRevenueMember 2022-09-30 0001308027 VYST:DeferredWarrantyRevenueMember 2021-12-31 0001308027 VYST:DeferredWarrantyRevenueMember 2022-01-01 2022-09-30 0001308027 VYST:DeferredWarrantyRevenueMember 2021-01-01 2021-09-30 0001308027 VYST:FurnitureFixturesAndEquipmentMember 2022-09-30 0001308027 VYST:FurnitureFixturesAndEquipmentMember 2021-12-31 0001308027 VYST:ToolingAndTestingEquipmentMember 2022-09-30 0001308027 VYST:ToolingAndTestingEquipmentMember 2021-12-31 0001308027 VYST:ParkingLotsMember 2022-09-30 0001308027 VYST:ParkingLotsMember 2021-12-31 0001308027 us-gaap:LeaseholdImprovementsMember 2022-09-30 0001308027 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001308027 us-gaap:VehiclesMember 2022-09-30 0001308027 us-gaap:VehiclesMember 2021-12-31 0001308027 us-gaap:CustomerRelationshipsMember 2022-09-30 0001308027 us-gaap:CustomerRelationshipsMember 2021-12-31 0001308027 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0001308027 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0001308027 VYST:ProprietaryTechnologyMember 2022-09-30 0001308027 VYST:ProprietaryTechnologyMember 2021-12-31 0001308027 VYST:ProprietaryTechnologyMember 2022-01-01 2022-09-30 0001308027 VYST:TradeNameandBrandMember 2022-09-30 0001308027 VYST:TradeNameandBrandMember 2021-12-31 0001308027 srt:MinimumMember VYST:TradeNameandBrandMember 2022-01-01 2022-09-30 0001308027 srt:MaximumMember VYST:TradeNameandBrandMember 2022-01-01 2022-09-30 0001308027 VYST:MarketingRelatedMember 2022-09-30 0001308027 VYST:MarketingRelatedMember 2021-12-31 0001308027 VYST:MarketingRelatedMember 2022-01-01 2022-09-30 0001308027 us-gaap:PatentsMember 2022-09-30 0001308027 us-gaap:PatentsMember 2021-12-31 0001308027 srt:MinimumMember us-gaap:PatentsMember 2022-01-01 2022-09-30 0001308027 srt:MaximumMember us-gaap:PatentsMember 2022-01-01 2022-09-30 0001308027 VYST:NonCompeteMember 2022-09-30 0001308027 VYST:NonCompeteMember 2021-12-31 0001308027 VYST:NonCompeteMember 2022-01-01 2022-09-30 0001308027 VYST:FidelityCoOperativeBankMember 2020-11-30 0001308027 VYST:OtherVendorsMember VYST:FidelityBankMember 2020-05-29 0001308027 VYST:PaycheckProtectionProgramMember 2020-04-15 2020-04-16 0001308027 VYST:PaycheckProtectionProgramMember VYST:PromissoryNoteMember 2020-04-16 0001308027 VYST:PaycheckProtectionProgramMember 2020-04-16 0001308027 VYST:PaycheckProtectionProgramMember 2021-02-01 2021-02-02 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2018-12-31 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2018-01-01 2018-12-31 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2022-09-30 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2021-12-31 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2022-04-01 2022-04-30 0001308027 VYST:ContingentlyConvertibleNotesPayableMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-09-30 0001308027 VYST:ConvertiblePromissoryNotesMember 2019-12-31 0001308027 srt:MinimumMember VYST:ConvertiblePromissoryNotesMember 2019-12-31 0001308027 srt:MaximumMember VYST:ConvertiblePromissoryNotesMember 2019-12-31 0001308027 VYST:ConvertiblePromissoryNotesMember 2022-04-01 2022-04-30 0001308027 VYST:ConvertiblePromissoryNotesMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-09-30 0001308027 VYST:ConvertiblePromissoryNotesMember 2021-12-31 0001308027 VYST:ConvertiblePromissoryNotesMember 2021-01-01 2021-12-31 0001308027 VYST:ShareholderContingentlyConvertibleNotesPayableMember 2021-12-31 0001308027 VYST:ShareholderContingentlyConvertibleNotesPayableMember 2022-09-30 0001308027 VYST:ConvertiblePromissoryNotesMember VYST:RotmanFamilyConvertibleNotesMember 2019-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesMember VYST:StevenRotmanMember 2019-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesMember VYST:GregRotmanMember 2019-09-30 0001308027 VYST:ConvertiblePromissoryNotesMember VYST:RotmanFamilyConvertibleNotesMember 2019-09-01 2019-09-30 0001308027 us-gaap:SeriesCPreferredStockMember VYST:StevenRotmanMember 2022-07-01 2022-07-31 0001308027 us-gaap:SeriesCPreferredStockMember VYST:GregRotmanMember 2022-07-01 2022-07-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesMember VYST:GregRotmanMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesOneMember 2019-07-18 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesOneMember VYST:StevenRotmanMember 2019-07-18 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesOneMember VYST:BernardRotmanMember 2019-07-18 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesOneMember VYST:RotmansMember 2019-07-18 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesOneMember 2019-07-17 2019-07-18 0001308027 us-gaap:SeriesCPreferredStockMember VYST:ConvertiblePromissoryNotesOneMember VYST:StevenRotmanMember 2022-07-01 2022-07-31 0001308027 us-gaap:SeriesCPreferredStockMember VYST:ConvertiblePromissoryNotesOneMember VYST:BernardRotmanMember 2022-07-01 2022-07-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesOneMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesOneMember VYST:BernardRotmanMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesTwoMember VYST:StevenRotmanMember 2019-12-19 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesTwoMember VYST:StevenRotmanMember 2019-12-18 2019-12-19 0001308027 us-gaap:SeriesCPreferredStockMember VYST:ConvertiblePromissoryNotesTwoMember 2022-07-01 2022-07-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesTwoMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesThreeMember VYST:StevenRotmanMember 2020-02-20 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesThreeMember VYST:StevenRotmanMember 2020-02-19 2020-02-20 0001308027 us-gaap:SeriesCPreferredStockMember VYST:ConvertiblePromissoryNotesThreeMember 2022-07-01 2022-07-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesThreeMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesFourMember VYST:GregoryRotmanMember 2021-06-03 0001308027 VYST:ConvertiblePromissoryNotesMember VYST:RotmanFamilyConvertibleNotesMember VYST:GregoryRotmanMember 2021-06-02 2021-06-03 0001308027 us-gaap:SeriesCPreferredStockMember VYST:ConvertiblePromissoryNotesFourMember 2022-07-01 2022-07-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesFourMember VYST:GregoryRotmanMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesFiveMember VYST:JamieRotmanMember 2021-08-17 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesFiveMember VYST:JamieRotmanMember 2021-08-16 2021-08-17 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesFiveMember VYST:JamieRotmanMember 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:ConvertiblePromissoryNotesFiveMember VYST:JamieRotmanMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember VYST:RotmansMember 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember VYST:StevenMember 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember VYST:BernardRotmanMember 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember VYST:StevenMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember VYST:BernardRotmanMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember VYST:BemardRotmanMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember 2022-01-01 2022-09-30 0001308027 us-gaap:SeriesCPreferredStockMember VYST:NonConvertiblePromissoryNotesMember 2022-07-01 2022-07-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember VYST:StevenMember 2021-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember VYST:NonConvertiblePromissoryNotesMember VYST:BernardRotmanMember 2021-12-31 0001308027 VYST:NonConvertiblePromissoryNotesOneMember VYST:StevenRotmanMember 2020-12-31 0001308027 us-gaap:SeriesCPreferredStockMember VYST:NonConvertiblePromissoryNotesOneMember 2022-07-01 2022-07-31 0001308027 VYST:NonConvertiblePromissoryNotesOneMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:NonConvertiblePromissoryNotesTwoMember VYST:StevenRotmanMember 2021-12-31 0001308027 us-gaap:SeriesCPreferredStockMember VYST:NonConvertiblePromissoryNotesTwoMember 2022-07-01 2022-07-31 0001308027 VYST:BlueOarConsultingIncMember 2022-04-01 2022-04-30 0001308027 VYST:BlueOarConsultingIncMember 2022-04-30 0001308027 VYST:RotmanFamilyConvertibleNotesMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyNonConvertibleNotesMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesOneMember 2022-09-30 0001308027 VYST:RotmanFamilyConvertibleNotesOneMember 2021-12-31 0001308027 VYST:RotmanFamilyNonConvertibleNotesMember 2022-09-30 0001308027 VYST:RotmanFamilyNonConvertibleNotesMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2022-09-30 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2022-01-01 2022-09-30 0001308027 VYST:GregoryRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2022-09-30 0001308027 VYST:GregoryRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2021-12-31 0001308027 VYST:GregoryRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2022-01-01 2022-09-30 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesTwoMember 2022-09-30 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesTwoMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesTwoMember 2022-01-01 2022-09-30 0001308027 VYST:BernardRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2022-09-30 0001308027 VYST:BernardRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2021-12-31 0001308027 VYST:BernardRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2022-01-01 2022-09-30 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesThreeMember 2022-09-30 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesThreeMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesThreeMember 2022-01-01 2022-09-30 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesFourMember 2022-09-30 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesFourMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyConvertibleNotesFourMember 2022-01-01 2022-09-30 0001308027 VYST:GregoryRotmanMember VYST:RotmanFamilyConvertibleNotesTwoMember 2022-09-30 0001308027 VYST:GregoryRotmanMember VYST:RotmanFamilyConvertibleNotesTwoMember 2021-12-31 0001308027 VYST:GregoryRotmanMember VYST:RotmanFamilyConvertibleNotesTwoMember 2022-01-01 2022-09-30 0001308027 VYST:JamieRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2022-09-30 0001308027 VYST:JamieRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2021-12-31 0001308027 VYST:JamieRotmanMember VYST:RotmanFamilyConvertibleNotesOneMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:StevenRotmanMember 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyNonconvertibleNotesOneMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:BernardRotmanMember 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:BernardRotmanMember 2021-12-31 0001308027 VYST:BernardRotmanMember VYST:RotmanFamilyNonconvertibleNotesOneMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesTwoMember VYST:StevenRotmanMember 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesTwoMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyNonconvertibleNotesTwoMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesThreeMember VYST:StevenRotmanMember 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesThreeMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyNonconvertibleNotesThreeMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesFourMember VYST:StevenRotmanMember 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesFourMember VYST:StevenRotmanMember 2021-12-31 0001308027 VYST:StevenRotmanMember VYST:RotmanFamilyNonconvertibleNotesFourMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:BlueOarMember 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:BlueOarMember 2021-12-31 0001308027 VYST:BlueOarMember VYST:RotmanFamilyNonconvertibleNotesOneMember 2022-01-01 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember 2022-09-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember 2021-12-31 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember 2013-05-02 0001308027 VYST:SeriesACumulativeConvertiblePreferredStockMember 2013-05-01 2013-05-02 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember 2013-05-01 2013-05-02 0001308027 VYST:HolderMember 2022-09-30 0001308027 VYST:HolderMember 2022-01-01 2022-09-30 0001308027 VYST:HolderMember 2021-12-31 0001308027 VYST:HolderMember 2021-01-01 2021-12-31 0001308027 VYST:SeriesBCumulativeConvertiblePreferredStockMember 2022-04-10 2022-04-11 0001308027 VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2022-04-11 0001308027 VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2022-04-10 2022-04-11 0001308027 VYST:HolderMember VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2022-09-30 0001308027 VYST:HolderMember VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001308027 VYST:SeriesCCumulativeConvertiblePreferredStockMember 2022-07-07 2022-07-08 0001308027 VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-07-08 0001308027 VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-07-07 2022-07-08 0001308027 VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-04-10 2022-04-11 0001308027 VYST:HolderMember VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-09-30 0001308027 VYST:HolderMember VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001308027 VYST:EquityPurchaseAgreementsMember 2022-01-01 2022-09-30 0001308027 VYST:StockSubscriptionAgreementMember 2022-09-30 0001308027 VYST:StockSubscriptionAgreementMember 2022-01-01 2022-09-30 0001308027 VYST:CaseGoodsMember VYST:BedroomFurnitureMember 2022-07-01 2022-09-30 0001308027 VYST:CaseGoodsMember VYST:BedroomFurnitureMember 2021-07-01 2021-09-30 0001308027 VYST:CaseGoodsMember VYST:BedroomFurnitureMember 2022-01-01 2022-09-30 0001308027 VYST:CaseGoodsMember VYST:BedroomFurnitureMember 2021-01-01 2021-09-30 0001308027 VYST:CaseGoodsMember VYST:DiningRoomFurnitureMember 2022-07-01 2022-09-30 0001308027 VYST:CaseGoodsMember VYST:DiningRoomFurnitureMember 2021-07-01 2021-09-30 0001308027 VYST:CaseGoodsMember VYST:DiningRoomFurnitureMember 2022-01-01 2022-09-30 0001308027 VYST:CaseGoodsMember VYST:DiningRoomFurnitureMember 2021-01-01 2021-09-30 0001308027 VYST:CaseGoodsMember VYST:OccasionalMember 2022-07-01 2022-09-30 0001308027 VYST:CaseGoodsMember VYST:OccasionalMember 2021-07-01 2021-09-30 0001308027 VYST:CaseGoodsMember VYST:OccasionalMember 2022-01-01 2022-09-30 0001308027 VYST:CaseGoodsMember VYST:OccasionalMember 2021-01-01 2021-09-30 0001308027 VYST:CaseGoodsMember 2022-07-01 2022-09-30 0001308027 VYST:CaseGoodsMember 2021-07-01 2021-09-30 0001308027 VYST:CaseGoodsMember 2022-01-01 2022-09-30 0001308027 VYST:CaseGoodsMember 2021-01-01 2021-09-30 0001308027 VYST:UpholsteryMember 2022-07-01 2022-09-30 0001308027 VYST:UpholsteryMember 2021-07-01 2021-09-30 0001308027 VYST:UpholsteryMember 2022-01-01 2022-09-30 0001308027 VYST:UpholsteryMember 2021-01-01 2021-09-30 0001308027 VYST:MattressesAndToppersMember 2022-07-01 2022-09-30 0001308027 VYST:MattressesAndToppersMember 2021-07-01 2021-09-30 0001308027 VYST:MattressesAndToppersMember 2022-01-01 2022-09-30 0001308027 VYST:MattressesAndToppersMember 2021-01-01 2021-09-30 0001308027 VYST:BroadloomFlooringAndRugsMember 2022-07-01 2022-09-30 0001308027 VYST:BroadloomFlooringAndRugsMember 2021-07-01 2021-09-30 0001308027 VYST:BroadloomFlooringAndRugsMember 2022-01-01 2022-09-30 0001308027 VYST:BroadloomFlooringAndRugsMember 2021-01-01 2021-09-30 0001308027 VYST:WarrantyMember 2022-07-01 2022-09-30 0001308027 VYST:WarrantyMember 2021-07-01 2021-09-30 0001308027 VYST:WarrantyMember 2022-01-01 2022-09-30 0001308027 VYST:WarrantyMember 2021-01-01 2021-09-30 0001308027 VYST:AirPurificationUnitsMember 2022-07-01 2022-09-30 0001308027 VYST:AirPurificationUnitsMember 2021-07-01 2021-09-30 0001308027 VYST:AirPurificationUnitsMember 2022-01-01 2022-09-30 0001308027 VYST:AirPurificationUnitsMember 2021-01-01 2021-09-30 0001308027 VYST:AccessoriesAndOtherMember 2022-07-01 2022-09-30 0001308027 VYST:AccessoriesAndOtherMember 2021-07-01 2021-09-30 0001308027 VYST:AccessoriesAndOtherMember 2022-01-01 2022-09-30 0001308027 VYST:AccessoriesAndOtherMember 2021-01-01 2021-09-30 0001308027 VYST:EmployeeAndBoardMembersMember 2022-01-01 2022-09-30 0001308027 VYST:EmployeeAndBoardMembersMember 2021-01-01 2021-09-30 0001308027 VYST:StockOptionPlanMember 2004-12-31 0001308027 VYST:StockOptionPlanMember 2009-04-01 2009-04-30 0001308027 VYST:StockOptionPlanMember 2022-09-30 0001308027 VYST:StockOptionPlanMember 2014-01-01 2014-12-31 0001308027 VYST:StockOptionPlanMember 2019-01-01 2019-12-31 0001308027 VYST:StockOptionPlanMember 2022-01-01 2022-09-30 0001308027 VYST:StockOptionsMember 2021-12-31 0001308027 VYST:StockOptionsMember 2022-01-01 2022-09-30 0001308027 VYST:StockOptionsMember 2022-09-30 0001308027 VYST:StockWarrantsMember 2021-12-31 0001308027 VYST:StockWarrantsMember 2022-01-01 2022-09-30 0001308027 VYST:StockWarrantsMember 2022-09-30 0001308027 VYST:PerStevenRotmanEmploymentAgreementMember VYST:PerYearMember 2019-07-21 2019-07-22 0001308027 VYST:PerStevenRotmanEmploymentAgreementMember VYST:PerMonthMember 2019-07-21 2019-07-22 0001308027 VYST:PerStevenRotmanEmploymentAgreementMember 2019-07-22 0001308027 VYST:PerStevenRotmanEmploymentAgreementMember 2019-07-21 2019-07-22 0001308027 VYST:EmploymentAgreementMember 2022-01-01 2022-09-30 0001308027 VYST:StockSubscriptionAgreementMember 2020-07-01 2020-07-31 0001308027 us-gaap:SeriesCPreferredStockMember VYST:OfficersAndDirectorsMember 2022-07-01 2022-09-30 0001308027 VYST:OfficersAndDirectorsMember 2022-07-01 2022-09-30 0001308027 VYST:StevenRotmanMember 2021-01-01 2021-12-31 0001308027 VYST:BlueOarConsultingIncMember VYST:BlueOarConsultingAgreementMember 2022-01-01 2022-09-30 0001308027 VYST:BlueOarConsultingIncMember VYST:BlueOarConsultingAgreementMember 2022-09-30 0001308027 VYST:BlueOarConsultingIncMember VYST:StockSubscriptionAgreementMember 2020-07-01 2020-07-31 0001308027 us-gaap:SeriesCPreferredStockMember VYST:BlueOarConsultingIncMember 2022-07-01 2022-09-30 0001308027 VYST:BlueOarConsultingIncMember 2022-07-01 2022-09-30 0001308027 VYST:GregoryRotmanMember 2022-09-30 0001308027 VYST:StevenRotmanMember 2022-09-30 0001308027 us-gaap:SeriesCPreferredStockMember VYST:BernardRotmanMember 2022-07-01 2022-09-30 0001308027 VYST:BernardRotmanMember 2022-07-01 2022-09-30 0001308027 VYST:FluidEnergyConversionIncMember 2019-05-01 2019-05-31 0001308027 VYST:FluidEnergyConversionIncMember 2021-01-01 2021-12-31 0001308027 us-gaap:SeriesBPreferredStockMember VYST:FluidEnergyConversionIncMember 2022-07-01 2022-07-31 0001308027 us-gaap:SeriesCPreferredStockMember VYST:FluidEnergyConversionIncMember 2022-07-01 2022-09-30 0001308027 VYST:RelatedPartyServicesExpensedMember 2022-01-01 2022-09-30 0001308027 VYST:BreachOfContractMember VYST:EMAFinancialIncMember 2022-01-01 2022-09-30 0001308027 VYST:PurchaseMember us-gaap:SupplierConcentrationRiskMember VYST:OneMajorVendorMember 2022-01-01 2022-09-30 0001308027 VYST:PurchaseMember us-gaap:SupplierConcentrationRiskMember VYST:OneMajorVendorMember 2022-09-30 0001308027 VYST:PurchaseMember us-gaap:SupplierConcentrationRiskMember VYST:OneMajorVendorMember 2021-01-01 2021-09-30 0001308027 VYST:PurchaseMember us-gaap:SupplierConcentrationRiskMember VYST:OneMajorVendorMember 2021-09-30 0001308027 us-gaap:TaxYear2021Member 2022-01-01 2022-09-30 0001308027 us-gaap:DomesticCountryMember 2022-09-30 0001308027 VYST:ExpiresBeginningInTwoThousandTwentyFourMember 2022-09-30 0001308027 VYST:CarriedForwardIndefinitelyMember 2022-09-30 0001308027 VYST:GeorgiaCountryMember 2022-09-30 0001308027 VYST:MassachusettsCountryMember 2022-09-30 0001308027 us-gaap:DomesticCountryMember VYST:RotmansFurnitureMember 2022-09-30 0001308027 VYST:ExpiresBeginningInTwoThousandTwentyNineMember us-gaap:DomesticCountryMember VYST:RotmansFurnitureMember 2022-09-30 0001308027 VYST:CarriedForwardIndefinitelyMember us-gaap:DomesticCountryMember VYST:RotmansFurnitureMember 2022-09-30 0001308027 us-gaap:StateAndLocalJurisdictionMember VYST:RotmansFurnitureMember us-gaap:TaxYear2022Member 2022-09-30 0001308027 VYST:ThirdPartyAgentMember 2022-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2022

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to ________________

 

Commission File Number 000-53754

 

VYSTAR CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Georgia   20-2027731

(State or other jurisdiction of

incorporation or organization)

  

(IRS Employer

Identification No.)

 

725 Southbridge St

Worcester, MA 01610

(Address of Principal Executive Offices, Zip Code)

 

(508) 791-9114

(Registrant’s telephone number including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
NONE   NONE   NONE

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☒   Smaller reporting company ☒
    Emerging growth company ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) YES ☐ NO ☒

 

Class   Outstanding as of December 6, 2022

Common Stock, $0.0001 par value per share

  

12,941,260 shares

 

 

 

 

 

 

INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS

 

In addition to historical information, this Form 10-Q contains statements relating to our future results (including certain projections and business trends) that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the “safe harbor” created by those sections. The following discussion of the financial condition and results of operations of the Company should be read in conjunction with the financial statements and the related notes thereto included in this Quarterly Report on Form 10-Q (this “Report”). This Report contains certain forward-looking statements and the Company’s future operating results could differ materially from those discussed herein. Our disclosure and analysis included in this Report concerning our operations, cash flows and financial position, including, in particular, the likelihood of our success in expanding our business and raising debt and capital securities include forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as “expect”, “anticipate”, “intend”, “plan”, “believe”, “estimate”, “may”, “project”, “will likely result”, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to certain risks, uncertainties, and assumptions, including prevailing market conditions and are more fully described under “Part I, Item 1A - Risk Factors” of our Form 10-K for the year ended December 31, 2021. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. In any event, these and other crucial factors, including those set forth in Item 1A - “Risk Factors” of our Form 10-K for the year ended December 31, 2021 may cause actual results to differ materially from those indicated by our forward-looking statements.

 

Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s opinions only as of the date of this filing. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements.

 

All references to “we”, “us”, “our” or “Vystar” in this Quarterly Report on Form 10-Q mean Vystar Corporation, and affiliates.

 

2

 

 

VYSTAR CORPORATION

 

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022

 

INDEX

 

Part I. Financial Information  
     
Item 1. Financial Statements:  
     
  Condensed Consolidated Balance Sheets at September 30, 2022 (unaudited) and December 31, 2021 4
     
  Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2022 (unaudited) and 2021 (unaudited) 5
     
  Condensed Consolidated Statements of Stockholders’ Deficit for the Three and Nine Months Ended September 30, 2022 (unaudited) and 2021 (unaudited) 6-7
     
  Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 (unaudited) and 2021 (unaudited) 8
     
  Notes to Condensed Consolidated Financial Statements (unaudited) 9
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 33
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 38
     
Item 4. Controls and Procedures 38
     
Part II. Other Information  
   
Item 1. Legal Proceedings 40
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 40
     
Item 3. Defaults Upon Senior Securities 40
     
Item 4. Mine Safety Disclosures 40
     
Item 5. Other Information 40
     
Item 6. Exhibits 40
     
SIGNATURES 41

 

3

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

                 
    September 30,     December 31,  
    2022     2021  
      (Unaudited)          
ASSETS                
Current assets:                
Cash   $ 160,686     $ 151,175  
Accounts receivable, net     43,667       68,541  
Other receivables     684,775       875,362  
Inventories     3,107,226       3,784,420  
Prepaid expenses and other     673,717       337,013  
Deferred commission costs     49,402       73,625  
                 
Total current assets     4,719,473       5,290,136  
                 
Property and equipment, net     670,638       832,099  
                 
Operating lease right-of-use assets     7,462,785       7,776,978  
                 
Finance lease right-of-use assets, net     441,326       551,037  
                 
Other assets:                
Intangible assets, net     949,934       1,208,870  
Goodwill     460,301       460,301  
Inventories, long-term     458,217       657,177  
Deferred commission costs, net of current portion     26,209       60,586  
Other     5,274       20,274  
                 
Total other assets     1,899,935       2,407,208  
                 
Total assets   $ 15,194,157     $ 16,857,458  
                 
LIABILITIES AND STOCKHOLDERS’ DEFICIT                
                 
Current liabilities:                
Accounts payable   $ 4,439,100     $ 5,149,570  
Accrued expenses     893,553       897,420  
Stock subscription payable     1,539,600       1,247,549  
Operating lease liabilities - current maturities     731,000       634,000  
Finance lease liabilities - current maturities     117,000       134,000  
Shareholder, convertible and contingently convertible notes payable and accrued interest - current maturities     332,248       1,388,904  
Related party debt - current maturities     616,025       1,487,000  
Unearned revenue     603,373       880,204  
Derivative liabilities     17,800       1,778,100  
Related party advances     92,731       -  
                 
Total current liabilities     9,382,430       13,596,747  
                 
Long-term liabilities:                
Operating lease liabilities, net of current maturities     5,376,050       5,683,736  
Finance lease liabilities, net of current maturities     355,328       443,882  
Unearned revenue, net of current maturities     104,835       241,991  
Related party debt, net of current maturities and debt discount     -       2,791,401  
                 
Total long-term liabilities     5,836,213       9,161,010  
                 
Total liabilities     15,218,643       22,757,757  
                 
Stockholders’ deficit:                
Convertible preferred stock series A, $0.0001 par value 15,000,000 shares authorized; 8,698 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively (liquidation preference of $81,055 and $74,531 at September 30, 2022 and December 31, 2021, respectively)     1       1  
Convertible preferred stock series B, $0.0001 par value 2,500,000 shares authorized; 370,969 and 0 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively (liquidation preference of $43,280 at September 30, 2022)     37       -  
Convertible preferred stock series C, $0.0001 par value 2,500,000 shares authorized; 1,917,973 and 0 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively (liquidation preference of $74,863 at September 30, 2022)     192       -  
Common stock, $0.0001 par value, 500,000,000 shares authorized; 12,941,760 shares issued at September 30, 2022 and December 31, 2021, and 12,941,260 and 12,941,460 shares outstanding at September 30, 2022 and December 31, 2021, respectively     1,294       1,294  
Additional paid-in capital     53,361,926       43,851,510  
Accumulated deficit     (54,492,803 )     (51,410,516 )
Common stock in treasury, at cost; 300 shares at September 30, 2022 and December 31, 2021, respectively     (30 )     (30 )
                 
Total Vystar stockholders’ deficit     (1,129,383 )     (7,557,741 )
                 
Noncontrolling interest     1,104,897       1,657,442  
                 
Total stockholders’ deficit     (24,486 )     (5,900,299 )
                 
Total liabilities and stockholders’ deficit   $ 15,194,157     $ 16,857,458  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

                                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2022     2021     2022     2021  
                         
Revenue   $ 3,572,071     $ 4,066,597     $ 10,607,362     $ 23,150,720  
                                 
Cost of revenue     1,681,713       1,932,290       4,809,951       10,576,205  
                                 
Gross profit     1,890,358       2,134,307       5,797,411       12,574,515  
                                 
Operating expenses:                                
Salaries, wages and benefits     866,427       1,188,835       2,560,840       4,713,623  
Share-based compensation     181,199       207,382       658,004       623,501  
Agent fees     312,909       312,214       1,058,095       2,641,654  
Professional fees     91,624       124,285       414,498       343,246  
Advertising     242,902       365,369       850,474       1,774,022  
Rent     195,950       331,056       556,861       967,287  
Service charges     90,132       147,466       282,376       456,481  
Depreciation and amortization     119,237       193,158       420,397       577,539  
Other operating     585,082       812,817       1,748,378       2,490,302  
                                 
Total operating expenses     2,685,462       3,682,582       8,549,923       14,587,655  
                                 
Loss from operations     (795,104 )     (1,548,275 )     (2,752,512 )     (2,013,140 )
                                 
Other income (expense):                                
Interest expense     (107,869 )     (186,732 )     (494,355 )     (540,062 )
Change in fair value of derivative liabilities     240,300       (88,200 )     1,760,300       (1,400 )
Gain (loss) on settlement of debt, net     (2,481,231 )     -       (2,250,411 )     2,675,926  
Other income, net     34,443       (135,612 )     102,147       (35,688 )
                                 
Total other income (expense), net     (2,314,357 )     (410,544 )     (882,319 )     2,098,776  
                                 
Net income (loss)     (3,109,461 )     (1,958,819 )     (3,634,831 )     85,636  
                                 
Net (income) loss attributable to noncontrolling interest     134,849       439,512       552,545       (823,363 )
                                 
Net loss attributable to Vystar   $ (2,974,612 )   $ (1,519,307 )   $ (3,082,286 )   $ (737,727 )
                                 
Loss per share:                                
Basic and diluted   $ (0.23 )   $ (0.12 )   $ (0.24 )   $ (0.06 )
                                 
Weighted average number of common shares outstanding:                                
Basic and diluted     12,941,260       12,816,505       12,941,279       12,627,241  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022

(Unaudited)

 

                                                                                                                         
    Attributable to Vystar                  
    Number           Number           Number           Number                       Number           Total              
    of           of           of           of           Additional           of           Vystar           Total  
    Preferred     Preferred     Preferred     Preferred     Preferred     Preferred     Common     Common     Paid-in     Accumulated     Treasury     Treasury     Stockholders’     Noncontrolling     Stockholders’  
    Shares A     Stock A     Shares B     Stock B     Shares C     Stock C     Shares     Stock     Capital     Deficit     Shares     Stock     Deficit     Interest     Deficit  
                                                                                                                         
Ending balance December 31, 2021              8,698     $ 1       -     $ -       -     $ -       12,941,760     $ 1,294     $ 43,851,510     $ (51,410,516 )     (300 )   $ (30 )   $        (7,557,741 )   $ 1,657,442     $        (5,900,299 )
                                                                                                                         
Share-based compensation - options                                                                     3,691                               3,691               3,691  
                                                                                                                         
Retirement of common stock                                                     (200 )                                                             -  
                                                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       (774,354 )     -       -       (774,354 )     (179,612 )     (953,966 )
                                                                                                                         
Ending balance March 31, 2022     8,698       1       -       -       -       -       12,941,560       1,294       43,855,201       (52,184,870 )     (300 )     (30 )     (8,328,404 )     1,477,830       (6,850,574 )
                                                                                                                         
Share-based compensation - options                                                                     3,691                               3,691               3,691  
                                                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       666,679       -       -       666,679       (238,084 )     428,595  
                                                                                                                         
Ending balance June 30, 2022     8,698       1       -       -       -       -       12,941,560       1,294       43,858,892       (51,518,191 )     (300 )     (30 )     (7,658,034 )     1,239,746       (6,418,288 )
                                                                                                                         
Share-based compensation - options                                                                     3,691                               3,691               3,691  
                                                                                                                         
Preferred stock issued for services                     73,428       7       291,188       29                       1,595,211                               1,595,247               1,595,247  
                                                                                                                         
Preferred stock issued for cash                                     32,566       3                       84,997                               85,000               85,000  
                                                                                                                         
Preferred stock issued for settlement of accounts payable                     127,857       13                                       511,415                               511,428               511,428  
                                                                                                                         
Preferred stock issued for settlement of shareholder notes payable                     152,755       15                                       893,602                               893,617               893,617  
                                                                                                                         
Preferred stock issued for settlement of related party notes payable                                     1,594,219       160                       6,346,404                               6,346,564               6,346,564  
                                                                                                                         
Preferred stock issued for settlement of stock payable                     16,929       2                                       67,714                               67,716               67,716  
                                                                                                                         
Net loss     -       -       -       -       -       -       -       -       -       (2,974,612 )     -       -       (2,974,612 )     (134,849 )     (3,109,461 )
                                                                                                                         
Ending balance September 30, 2022     8,698     $ 1       370,969     $ 37       1,917,973     $ 192       12,941,560     $ 1,294     $ 53,361,926     $ (54,492,803 )     (300 )   $ (30 )   $ (1,129,383 )   $ 1,104,897     $ (24,486 )

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6

 

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021

(Unaudited)

 

                                                                                         
    Attributable to Vystar              
    Number           Number                       Number           Total              
    of           of           Additional           of           Vystar           Total  
    Preferred     Preferred     Common     Common     Paid-in     Accumulated     Treasury     Treasury     Stockholders’     Noncontrolling     Stockholders’  
    Shares     Stock     Shares     Stock     Capital     Deficit     Shares     Stock     Deficit     Interest     Deficit  
                                                                   
Ending balance December 31, 2020     13,698     $ 1       11,999,318     $ 1,200     $ 41,352,261     $ (48,713,184 )     (300 )   $ (30 )   $         (7,359,752 )   $ 600,795     $         (6,758,957 )
                                                                                         
Common stock issued for services                     493,718       49       1,404,043                               1,404,092               1,404,092  
                                                                                         
Share-based compensation - options                                     4,916                               4,916               4,916  
                                                                                         
Common stock issued for settlement of related party payable                     113,650       11       335,254                               335,265               335,265  
                                                                                         
Common stock issued for cash received in prior period                     16,667       2      

24,998

                             25,000               25,000  
                                                                                         
Preferred stock conversion     (5,000 )             17,680       2       (2 )                             -               -  
                                                                                         
Net income     -       -       -       -       -       918,127       -       -       918,127       1,053,065       1,971,192  
                                                                                         
Ending balance March 31, 2021     8,698       1       12,641,033       1,264       43,121,470       (47,795,057 )     (300 )     (30 )     (4,672,352 )     1,653,860       (3,018,492 )
                                                                                         
Share-based compensation - options                                     3,691                               3,691               3,691  
                                                                                         
Net income (loss)     -       -       -       -       -       (136,547 )     -       -       (136,547 )     209,810       73,263  
                                                                                         
Ending balance June 30, 2021     8,698       1       12,641,033       1,264       43,125,161       (47,931,604 )     (300 )     (30 )     (4,805,208 )     1,863,670       (2,941,538 )
                                                                                         
Common stock issued for services                     292,060       29       705,968                               705,997               705,997  
                                                                                         
Share-based compensation - options                                     3,691                               3,691               3,691  
                                                                                         
Common stock issued for settlement of related party payable                     8,667       1       12,999                               13,000               13,000  
                                                                                         
Net loss     -       -       -       -       -       (1,519,307 )     -       -       (1,519,307 )     (439,512 )     (1,958,819 )
                                                                                         
Ending balance September 30, 2021     8,698       1       12,941,760     $ 1,294     $ 43,847,819     $ (49,450,911 )     (300 )   $ (30 )   $ (5,601,827 )   $ 1,424,158     $ (4,177,669 )

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

7

 

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

                 
    Nine Months Ended  
    September 30,  
    2022     2021  
Cash flows from operating activities:                
Net income (loss)   $ (3,634,831 )   $ 85,636  
Adjustments to reconcile net income (loss) to net cash used in operating activities:                
(Gain) loss on settlement of debt, net     2,250,411       (2,675,926 )
Share-based compensation     658,004       623,501  
Depreciation     161,461       289,569  
Bad debts (recovery)     (3,754 )     132,702  
Amortization of intangible assets     258,936       287,970  
Noncash lease expense     217,958       229,093  
Amortization of debt discount     27,083       26,335  
Change in fair value of derivative liabilities     (1,760,300 )     1,400  
Loss on sale of property and equipment     -       170,801  
Gain on sale of investments     -       (16,300 )
(Increase) decrease in assets:                
Accounts receivable     28,629       (338,848 )
Other receivables     190,587       -  
Inventories     876,154       1,275,713  
Prepaid expenses and other     184,376       163,492  
Deferred commission costs     58,600       83,205  
Increase (decrease) in liabilities:                
Accounts payable     332,551       (149,465 )
Accrued expenses and interest payable     172,696       (2,077,141 )
Unearned revenue     (413,988 )     (880,266 )
                 
Net cash used in operating activities     (395,427 )     (2,768,529 )
                 
Cash flows from investing activities:                
Acquisition of property and equipment     -       (54,157 )
Proceeds from the sale of property and equipment     -       311,300  
Proceeds from the sales of investments     -       144,210  
Patents and trademark fees     -       (2,183 )
                 
Net cash provided by investing activities     -       399,170  
                 
Cash flows from financing activities:                
Proceeds from issuance of term debt     -       1,402,900  
Proceeds from the issuance of notes - related parties     500,000       533,039  
Proceeds from the issuance of convertible notes payable     -       290,000  
Proceeds from related party advances     92,731       -  
Repayment of related party debt     (162,500 )     -  
Repayment of finance lease obligations     (110,293 )     (130,488 )
Proceeds from issuance of preferred stock     85,000       -  
                 
Net cash provided by financing activities     404,938       2,095,451  
                 
Net increase (decrease) in cash     9,511       (273,908 )
                 
Cash - beginning of period     151,175       620,539  
                 
Cash - end of period   $ 160,686     $ 346,631  
                 
Cash paid during the period for:                
Interest   $ 287,521     $ 331,849  
                 
Non-cash transactions:                
Common stock issued for accrued compensation   $ -     $ 2,110,089  
Common stock issued for settlement of related party payable     -       335,265  
Common stock issued for cash received in prior period     -       38,000  
Common stock issued for preferred stock     -       177  
Prepaid expenses with common stock     -       291,000  
Prepaid expenses with preferred stock     506,080       -  
Notes payable paid with preferred stock     1,124,436       -  
Related party notes payable paid with preferred stock     4,254,992          
Warrants and consulting paid by preferred stock     58,500       -  
Preferred stock issued for stock subscription payable     103,750       -  
Vendor payables paid with preferred stock     943,021       -  
Vendor payables paid directly by related party     100,000       -  
Reduction of third-party vendor payable with transfer of inventories     -       2,886,497  
Acquisition of inventories with third-party vendor payable at commencement of second sale agreement     -       2,886,497  
Derivatives issued as a debt discount     -       65,000  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

8

 

 

VYSTAR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 - DESCRIPTION OF BUSINESS

 

Nature of Business

 

Vystar Corporation (“Vystar”, the “Company”, “we,” “us,” or “our”) is based in Worcester, Massachusetts. The Company uses patented technology to produces a line of innovative air purifiers, which destroy viruses and bacteria through the use of ultraviolet light. Vystar is also the creator and exclusive owner to produce Vytex® Natural Rubber Latex (“NRL”) currently being used primarily in various bedding products. In addition, Vystar has a majority ownership in Murida Furniture Co., Inc. dba Rotmans Furniture (“Rotmans”), one of the largest independent furniture retailers in the U.S.

 

On September 1, 2022, our amendment effecting a 1-for-100 reverse stock split of our common stock was effective, which was previously approved by our Board of Directors on July 26, 2022. The total number of shares which the Company is authorized to issue is 520,000,000, of which 500,000,000 is common and 20,000,000 is preferred. All share and per share amounts have been adjusted in these condensed consolidated financial statements to reflect the effects of the reverse stock split. The Company is awaiting FINRA approval to effectuate the reverse stock split.

 

NOTE 2 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for the fair presentation of the condensed consolidated financial statements have been included. Such adjustments are of a normal, recurring nature. The condensed consolidated financial statements, and the accompanying notes, are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and do not contain certain information included in the Company’s Annual Report and Form 10-K for the year ended December 31, 2021. Therefore, the interim condensed consolidated financial statements should be read in conjunction with that Annual Report on Form 10-K.

 

The Company has evaluated subsequent events through the date of the filing of its Form 10-Q with the Securities and Exchange Commission. Other than those events disclosed in Note 18, the Company is not aware of any other significant events that occurred subsequent to the balance sheet date but prior to the filing of this report that would have a material impact on the Company’s financial statements.

 

Basis of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned or controlled operating subsidiaries. All significant intercompany accounts and transactions have been eliminated.

 

COVID-19 and Economic Conditions

 

The novel coronavirus (“COVID-19”) pandemic, its contributory efforts on the economy and general economic conditions, continues to impact our business and results of operations. During the nine months ended September 30, 2022, we experienced rising product prices, volatile transportation costs and supply chain disruptions. In addition, discretionary consumer spending has been adversely impacted by rising inflation, including fuel costs and interest rates. We cannot reasonably estimate the extent and duration of any future impact from the COVID-19 pandemic or general economic conditions on our business. Accordingly, the estimates and assumptions made as of September 30, 2022 could change in subsequent interim reports, and it is reasonably possible that such changes could be significant (although the potential effects cannot be measured at this time).

 

Segment Reporting

 

Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company’s chief operating decision maker is the chief executive officer. The Company and the chief executive officer view the Company’s operations and manage its business as one reportable segment with different operating segments.

 

9

 

 

Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Significant estimates made by management include, among others, allowance for obsolete inventory, the recoverability of long-lived assets, valuation and impairment of intangible assets, fair values of right of use assets and lease liabilities, valuation of derivative liabilities, share-based compensation and other equity issuances. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results could differ from these estimates.

 

Fair Value of Financial Instruments

 

The Company’s financial instruments consist principally of cash, accounts receivable, accounts payable, accrued expenses and interest payable, shareholder notes payable, long-term debt and unearned revenue. The carrying values of all the Company’s financial instruments approximate or equal fair value because of their short maturities and market interest rates or, in the case of equity securities, being stated at fair value.

 

In specific circumstances, certain assets and liabilities are reported or disclosed at fair value. Fair value is the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the Company’s principal market for such transactions. If there is not an established principal market, fair value is derived from the most advantageous market.

 

Valuation inputs are classified in the following hierarchy:

 

  ● Level 1 inputs are unadjusted quoted prices in active markets for identical assets or liabilities.
  ● Level 2 inputs are directly or indirectly observable valuation inputs for the asset or liability, excluding Level 1 inputs.
  ● Level 3 inputs are unobservable inputs for the asset or liability.

 

Highest priority is given to Level 1 inputs and the lowest priority to Level 3 inputs. Acceptable valuation techniques include the market approach, income approach, and cost approach. In some cases, more than one valuation technique is used. The derivative liabilities were recognized at fair value on a recurring basis through the date of the settlement and September 30, 2022 and are level 3 measurements. There have been no transfers between levels during the nine months ended September 30, 2022.

 

Acquisitions

 

Amounts paid for acquisitions are allocated to the assets acquired and liabilities assumed based on their estimated fair value at the date of acquisition. The fair value of identifiable intangible assets is based on valuations that use information and assumptions provided by management. Identifiable intangible assets with finite lives are amortized over their useful lives. Acquisition-related costs, including, legal, accounting, and other costs, are capitalized in asset acquisitions and for business combinations are expensed in the periods in which the costs are incurred. The results of operations of acquired assets are included in the financial statements from the acquisition date.

 

Cash, Cash Equivalents and Restricted Cash

 

Cash and cash equivalents include all liquid investments with a maturity date of less than three months when purchased. Cash equivalents also include amounts due from third-party financial institutions for credit and debit card transactions which typically settle within five days. Restricted cash represents cash balances restricted as to withdrawal or use and are included in prepaid expenses and other on the condensed consolidated balance sheets.

 

10

 

 

Accounts Receivable, Net

 

Accounts receivable, net are stated at the amount management expects to collect from outstanding balances. The Company routinely sells, without recourse, trade receivables resulting from retail furniture sales to two financial institutions at an average service charge of 3% in 2022. Amounts sold during the nine months ending September 30, 2022 were approximately $3,067,000. Retail furniture receivables retained by the Company are generally collateralized by the merchandise sold, represent valid claims against debtors for sales arising on or before the balance sheet date and are reduced to their estimated net realizable value. In addition, the Company grants credit to Vystar customers without requiring collateral. The amount of accounting loss for which Vystar is at risk in these unsecured accounts receivable is limited to their carrying value. Management provides for uncollectible amounts through a charge to earnings and a credit to an allowance for doubtful accounts based upon its assessment of the current status of individual accounts. Balances that are still outstanding after management has performed reasonable collection efforts are written off through a charge to the allowance and a credit to accounts receivable. As of September 30, 2022 and December 31, 2021, the Company has recorded an allowance for doubtful accounts of $267,000 and $273,000, respectively.

 

Other Receivables

 

Under the provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) signed into law on March 27, 2020 and the subsequent extension of the CARES Act, the Company was eligible for a refundable employee retention credit subject to certain criteria. The Company recognized employee retention credits of $771,287 during the year ended December 31, 2021 which has been included in other income, net in the consolidated statements of operations. The Company has filed for refunds of the employee retention credits and as of the date of this Quarterly Report on Form 10-Q has subsequently received $154,468 and estimates receiving the remaining refunds by the end of 2022.

 

Rotmans terminated its agreement with a supplier in 2021 and will receive $100,000 in consideration. As of December 31, 2021, the remaining account balance of $104,075 represents funds due from this termination. The Company has received $37,408 during the nine months ended September 30, 2022.

 

Inventories

 

Inventories include those costs directly attributable to the product before sale. Inventories consist primarily of finished goods of furniture, mattresses, RxAir purifier units, foam toppers and pillows and are carried at net realizable value, which is defined as selling price less cost of completion, disposal and transportation. The Company evaluates the need to record write-downs for inventory on a regular basis. Appropriate consideration is given to obsolescence, slow-moving and other factors in evaluating net realizable values. Inventories not expected to be sold within 12 months are classified as long-term.

 

Prepaid Expenses and Other

 

Prepaid expenses and other include restricted cash, amounts related to prepaid insurance policies, which are expensed on a straight-line basis over the life of the underlying policy, and other expenses.

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided over the estimated useful lives of the assets, generally 5 to 10 years, using straight-line and accelerated methods.

 

Expenditures for major renewals and betterments are capitalized, while routine repairs and maintenance are expensed as incurred. When property items are retired or otherwise disposed of, the asset and related reserve accounts are relieved of the cost and accumulated depreciation, respectively, and the resultant gain or loss is reflected in earnings. As of September 30, 2022, the net balance of property and equipment is $670,638 with accumulated depreciation of $805,445. As of December 31, 2021, the net balance of property and equipment is $832,099 with accumulated depreciation of $643,984.

 

11

 

 

Intangible Assets

 

Patents represent legal and other fees associated with the registration of patents. The Company has five issued patents with the United States Patent and Trade Office (“USPTO”) as well as five issued international Patent Cooperation Treaty (“PCT”) patents. Patents are carried at cost and are being amortized on a straight-line basis over their estimated useful lives, typically ranging from 9 to 20 years.

 

The Company has trademark protection for “Vystar”, “Vytex”, and “RxAir” among others. Trademarks are carried at cost and since their estimated life is indeterminable, no amortization is recognized. Instead, they are evaluated annually for impairment.

 

Customer relationships, tradename and marketing related intangibles are carried at cost and are being amortized on a straight-line basis over their estimated useful lives, typically ranging from 5 to 10 years.

 

Our intangible assets are reviewed for impairment annually or more frequently as warranted by events of changes in circumstances. As disclosed in Note 18, Rotmans will be closing its showroom at the end of 2022. At that time, the carrying amounts of our intangible assets may not be fully recoverable and an impairment charge will be recorded.

 

Long-Lived Assets

 

We review our long-lived assets for impairment whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. We evaluate assets for potential impairment by comparing estimated future undiscounted net cash flows to the carrying amount of the assets. If the carrying amount of the assets exceeds the estimated future undiscounted cash flows, impairment is measured based on the difference between the carrying amount of the assets and fair value. Assets to be disposed of would be separately presented in the condensed consolidated balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and are no longer depreciated. The assets and liabilities of a disposal group classified as held-for-sale would be presented separately in the appropriate asset and liability sections of the condensed consolidated balance sheet, if material. During the nine months ended September 30, 2022 and 2021, we did not recognize any impairment of our long-lived assets. As disclosed in Note 18, Rotmans will be closing its showroom at the end of 2022. At that time, the carrying amounts of the assets may not be fully recoverable and an impairment charge will be recorded.

 

Goodwill

 

Goodwill reflects the cost of an acquisition in excess of the fair values assigned to identifiable net assets acquired. Goodwill is not amortized, rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. We perform our annual impairment test at the end of each calendar year, or more frequently if events or changes in circumstances indicate the asset might be impaired.

 

Accounting for acquisitions requires us to recognize, separately from goodwill, the assets acquired and the liabilities assumed at their acquisition-date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred and the net of the acquisition-date fair values of the assets acquired and the liabilities assumed. While we use best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, the estimates are inherently uncertain and subject to refinement.

 

The impairment model permits, and we utilize, a simplified approach for determining goodwill impairment. In the first step, we evaluate the recoverability of goodwill by estimating the fair value of our reporting unit using multiple techniques, including an income approach using a discounted cash flow model and a market approach. Based on an equal weighting of the results of these two approaches, a conclusion of fair value is estimated. The fair value is then compared to the carrying value of our reporting unit. If the fair value of a reporting unit is less than its carrying value, the Company recognizes this amount as an impairment loss. Impairment losses, limited to the carrying value of goodwill, represent the excess of the carrying amount of goodwill over its implied fair value.

 

As disclosed in Note 18, Rotmans will be closing its showroom at the end of 2022. At that time, goodwill will be reviewed and, if impaired, a loss will be recorded.

 

Convertible Notes Payable

 

Borrowings are recognized initially at the principal amount received. Borrowings are subsequently carried at amortized cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognized as interest expense in the statements of operations over the period of the borrowings using the effective interest method.

 

12

 

 

Derivatives

 

The Company evaluates its debt instruments or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under the relevant sections of Accounting Standards Codification (“ASC”) Topic 815-40, Derivative Instruments and Hedging: Contracts in Entity’s Own Equity. The result of this accounting treatment could be that the fair value of a financial instrument is classified as a derivative instrument and is marked-to-market at each balance sheet date and recorded as a liability. In the event the fair value is recorded as a liability, the change in fair value is recorded in the statements of operations as other income or other expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Financial instruments that are initially classified as equity that become subject to reclassification under ASC Topic 815-40 are reclassified to a liability account at the fair value of the instrument on the reclassification date.

 

The Company applies the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity’s own stock. The standard applies to any freestanding financial instrument or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity’s own common stock. From time to time, the Company has issued notes with embedded conversion features. Certain of the embedded conversion features contain price protection or anti-dilution features that result in these instruments being treated as derivatives for accounting purposes. Accordingly, as of September 30, 2022, the Company has classified all conversion features as derivative liabilities and has estimated the fair value of these embedded conversion features using a Monte Carlo simulation model.

 

Unearned Revenue

 

Unearned revenue consists of customer advance payments, deposits on sales of undelivered merchandise and deferred warranty revenue on self-insured stain protection warranty coverage.

 

Changes to unearned revenue during the nine months ended September 30, 2022 and 2021 are summarized as follows:

 

                 
    2022     2021  
             
Balance, beginning of the period   $ 1,122,195     $ 2,427,771  
                 
Customer deposits received     9,368,761       20,250,952  
                 
Gift cards purchased     1,200       9,610  
                 
Revenue earned     (9,783,948 )     (21,140,827 )
                 
Balance, end of the period   $ 708,208     $ 1,547,506  

 

Loss Per Share

 

The Company presents basic and diluted loss per share. As the Company reported a net loss in the nine months ended September 30, 2022 and 2021, common stock equivalents, including stock options and warrants, were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same. Excluded from the computation of diluted loss per share were options to purchase 266,000 and 267,500 shares of common stock for the nine months ended September 30, 2022 and 2021, respectively, as their effect would be anti-dilutive. Warrants to purchase 38,483 and 104,928 shares of common stock for the nine months ended September 30, 2022 and 2021, respectively, were also excluded from the computation of diluted loss per share as their effect would be anti-dilutive. In addition, preferred stock series A convertible to 33,607 and 31,868 shares of common stock for the nine months ended September 30, 2022 and 2021, respectively, were excluded from the computation of diluted loss per share as their effect would be anti-dilutive. Preferred stock series B and C convertible to 3,771,152 and 19,466,562 shares of common stock for the nine months ended September 30, 2022 were excluded from the computation of diluted loss per share as their effect would be anti-dilutive. Both shareholder and Rotman Family contingently convertible notes of 2,249,987 and 3,862,190 shares of common stock for the nine months ended September 30, 2022 and 2021, respectively, were also excluded from the computation of diluted loss per share as their effect would be anti-dilutive.

 

13

 

 

Revenue

 

Our principal activities from which we generate our revenue are product sales. Revenue is measured based on considerations specified in a contract with a customer. A contract exists when it becomes a legally enforceable agreement with a customer. The contract is based on either the acceptance of standard terms and conditions at the retail store and on the websites for e-commerce customers, or the execution of terms and conditions contracts with retailers and wholesalers. These contracts define each party’s rights, payment terms and other contractual terms and conditions of the sale.

 

Consideration is typically paid prior to shipment via credit card or check when our products are sold direct to consumers, which is typically within 1 to 2 days or approximately 30 days from the time control is transferred when sold to wholesalers, distributors and retailers. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience and, in some circumstances, published credit and financial information pertaining to the customer.

 

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for us is transfer of finished goods to our customers. Performance obligations promised in a contract are identified based on the goods that will be transferred to the customer that are both capable of being distinct and are distinct in the context of the contract, whereby the transfer of the goods is separately identifiable from other promises in the contract. We have concluded the sale of finished goods and related shipping and handling are accounted for as the single performance obligation.

 

The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation. The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods to the customer. We issue refunds to retail, e-commerce and print media customers, upon request, within 30 days of delivery. We estimate the amount of potential refunds at each reporting period using a portfolio approach of historical data, adjusted for changes in expected customer experience, including seasonality and changes in economic factors. For retailers, distributors and wholesalers, we do not offer a right of return or refund and revenue is recognized at the time products are shipped to customers. In all cases, judgment is required in estimating these reserves. Actual claims for returns could be materially different from the estimates. As of September 30, 2022 and December 31, 2021, reserves for estimated sales returns totaled $281,000 and $337,000, respectively, and are included in the accompanying condensed consolidated balance sheets as accrued expenses.

 

We recognize revenue when we satisfy a performance obligation in a contract by transferring control over a product to a customer when product is shipped based on fulfillment by the Company. The Company considers fulfillment when it passes all liability at the point of shipping through third party carriers or in-house delivery services. Delivery fees are charged to customers and are included in revenue in the accompanying condensed consolidated statements of operations and the costs associated with these deliveries are included in revenues as a third-party delivery service is engaged. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of revenue in the accompanying condensed consolidated statements of operations.

 

The Company also defers revenues for separately-priced stain protection warranty coverage for which it is ultimately self-insured. Revenue is recognized from the extended warranty sales on a straight-line basis over the respective contract term. The extended warranty terms primarily range from three to five years from the date of delivery. The Company ended this warranty program during 2020 but continues to amortize the previously contracted warranties over their original terms. The Company currently offers a separately-priced stain protection warranty serviced by a third-party. At September 30, 2022 and December 31, 2021, deferred warranty revenue was approximately $301,000 and $524,000, respectively, and is included in unearned revenue in the accompanying consolidated balance sheets. During the nine months ended September 30, 2022 and 2021, the Company recognized total revenues of approximately $217,000 and $308,000, respectively, related to deferred warranty revenue arrangements. Commission costs in obtaining extended warranty contracts are capitalized and recognized as expense on a straight-line basis over the period of the warranty contract. At September 30, 2022 and December 31, 2021, deferred commission costs were approximately $76,000 and $134,000, respectively, and are included in the accompanying condensed consolidated balance sheets. All other costs, such as costs of services performed under the contract, general and administrative expenses, and advertising costs are expensed as incurred.

 

14

 

 

Cost of Revenue

 

Cost of revenue consists primarily of product and freight costs and fees paid to online retailers.

 

Research and Development

 

Research and development costs are expensed when incurred. Research and development costs include all costs incurred related to the research, development and testing. For the nine months ended September 30, 2022 and 2021, Vystar’s research and development costs were not significant.

 

Advertising Costs

 

Advertising costs, which include television, radio, newspaper, digital and other media advertising, are expensed upon first showing. Advertising costs were approximately $850,000 and $1,774,000 for the nine months ended September 30, 2022 and 2021, respectively.

 

Share-Based Compensation

 

The fair value of stock options is estimated on the grant date using the Black-Scholes option pricing model, based on weighted average assumptions. Expected volatility is based on historical volatility of our common stock. The Company has elected to use the simplified method described in the Securities and Exchange Commission Staff Accounting Bulletin Topic 14C to estimate the expected term of employee stock options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The value of restricted stock awards is determined using the fair value of the Company’s common stock on the date of grant. The Company accounts for forfeitures as they occur. Compensation expense is recognized on a straight-line basis over the requisite service period of the award.

 

Income Taxes

 

Vystar recognizes income taxes on an accrual basis based on a tax position taken or expected to be taken in its tax returns. A tax position is defined as a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets or liabilities. Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold will be measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement. Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in our financial statements or tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more likely than not be realized. Should they occur, interest and penalties related to tax positions are recorded as interest expense. No such interest or penalties have been incurred for the nine months ended September 30, 2022 and 2021.

 

The Company remains subject to income tax examinations from Federal and state taxing jurisdictions for 2019 through 2021.

 

Concentration of Credit Risk

 

Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash and accounts receivable. Cash held in operating accounts may exceed the Federal Deposit Insurance Corporation, or FDIC, insurance limits. While the Company monitors cash balances in our operating accounts on a regular basis and adjust the balances as appropriate, these balances could be impacted if the underlying financial institutions fail. To date, the Company has experienced no loss or lack of access to our cash; however, the Company can provide no assurances that access to our cash will not be impacted by adverse conditions in the financial markets. Credit concentration risk related to accounts receivable is mitigated as customer credit is checked prior to the sales.

 

15

 

 

Other Risks and Uncertainties

 

The Company is exposed to risks pertinent to the operations of a retailer, including, but not limited to, the ability to acquire new customers and maintain a strong brand as well as broader economic factors such as interest rates and changes in customer spending patterns.

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). The new ASU eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity’s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. The amendments in the ASU are effective for public business entities that meet the definition of an SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board also specified that an entity should adopt the guidance as of the beginning of its annual fiscal year and is not permitted to adopt the guidance in an interim period. The Company is still evaluating the effect the adoption will have on its financial statements.

 

NOTE 3 - LIQUIDITY AND GOING CONCERN

 

The Company’s financial statements are prepared using the accrual method of accounting in accordance with U.S. GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. However, the Company has incurred significant losses and experienced negative cash flow since inception. At September 30, 2022, the Company had cash of $160,686 and a deficit in working capital of approximately $4.6 million. Further, at September 30, 2022 the accumulated deficit amounted to approximately $54.5 million. We use working capital to finance our ongoing operations, and since those operations do not currently cover all our operating costs, managing working capital is essential to our Company’s future success. Because of this history of losses and financial condition, as well as the Rotmans going out of business sale as discussed in Note 18, there is substantial doubt about the Company’s ability to continue as a going concern.

 

A successful transition to attaining profitable operations is dependent upon obtaining sufficient financing to fund the Company’s planned expenses and achieving a level of revenue adequate to support the Company’s cost structure. Management plans to finance future operations using cash on hand, increased revenue from RxAir air purification units, Vytex license fees and stock issuances to new and existing shareholders.

 

There can be no assurances the Company will be able to achieve projected levels of revenue in 2022 and beyond. If the Company is not able to achieve projected revenue and obtain alternate additional financing of equity or debt, the Company would need to significantly curtail or reorient operations during 2022, which could have a material adverse effect on the ability to achieve the business objectives, and as a result, may require the Company to file bankruptcy or cease operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions.

 

16

 

 

The Company’s future expenditures will depend on numerous factors, including: the rate at which the Company can introduce RxAir air purification units and license Vytex NRL raw materials to manufacturers, and subsequently retailers; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; market acceptance of the Company’s products, services and competing technological developments; the Company’s ability to successfully acquire new customers and maintain a strong brand; and broader economic factors such as interest rates and changes in customer spending patterns. As the Company expands its activities and operations, cash requirements are expected to increase at a rate consistent with revenue growth after the Company has achieved sustained revenue generation.

 

NOTE 4 - INVESTMENTS – EQUITY SECURITIES

 

Investments, which represented equity securities in a publicly traded company, were sold during the nine months ended September 30, 2021 at a gain of approximately $16,000 which is included in other income (expense).

 

NOTE 5 - PROPERTY AND EQUIPMENT

 

Property and equipment, net consists of the following:

 

                 
    September 30,     December 31,  
    2022     2021  
             
Furniture, fixtures and equipment   $ 588,624     $ 588,624  
Tooling and testing equipment     338,572       338,572  
Parking lots     365,707       365,707  
Leasehold improvements     134,014       134,014  
Motor vehicles     49,166       49,166  
                 
Property and equipment, gross     1,476,083       1,476,083  
Accumulated depreciation     (805,445 )     (643,984 )
                 
Property and equipment, net   $ 670,638     $ 832,099  

 

Depreciation expense for the nine months ended September 30, 2022 and 2021 was $161,461 and $289,569, respectively.

 

17

 

 

NOTE 6 - INTANGIBLE ASSETS

 

Intangible assets consist of the following:

 

                     
    September 30,     December 31,     Amortization Period
    2022     2021     (in Years)
Amortized intangible assets:              
Customer relationships   $ 150,000     $ 150,000     6 - 10
Proprietary technology     280,000       280,000     10
Tradename and brand     1,050,000       1,050,000     5 - 10
Marketing related     380,000       380,000     5
Patents     361,284       361,284     6 - 20
Noncompete     50,000       50,000     5
                   
Total     2,271,284       2,271,284      
Accumulated amortization     (1,330,422 )     (1,071,486 )    
                     
Intangible assets, net     940,862       1,199,798      
Indefinite-lived intangible assets:                    
Trademarks     9,072       9,072      
                     
Total intangible assets   $ 949,934     $ 1,208,870      

 

Amortization expense for the nine months ended September 30, 2022 and 2021 was $258,936 and $287,970, respectively.

 

Estimated future amortization expense for finite-lived intangible assets is as follows:

 

         
    Amount  
       
Remaining in 2022   $ 86,313  
2023     338,638  
2024     239,411  
2025     90,550  
2026     71,232  
Thereafter     114,718  
         
Total   $ 940,862  

 

18

 

 

NOTE 7 - LEASES

 

The Company leases equipment, a showroom, offices and warehouse facilities. These leases expire at various dates through 2024 with options to extend to 2031.

 

The table below presents the lease costs for the three and nine months ended September 30, 2022 and 2021:

 

                                 
    Three Months Ended     Nine Months Ended  
    September 30.     September 30,  
    2022     2021     2022     2021  
                         
Operating lease cost   $ 289,824     $ 396,937     $ 865,628     $ 1,189,481  
                                 
Finance lease cost:                                
                                 
Amortization of right-of-use assets     30,276       45,912       114,450       137,736  
Interest on lease liabilities     8,342       8,371       22,439       26,792  
                                 
Total lease cost   $ 328,442     $ 451,220     $ 1,002,517     $ 1,354,009  

 

During the nine months ended September 30, 2022 and 2021, the Company recognized sublease income of approximately $102,000 and $81,000, respectively, which is included in other income (expense), net in the accompanying condensed consolidated statements of operations.

 

Our leases generally do not provide an implicit rate, and therefore we use our incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of the lease. We used incremental borrowing rates as of the implementation date for operating leases that commenced prior to that date.

 

The following table presents other information related to leases:

 

                                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2022     2021     2022     2021  
                         
Cash paid for amounts included in the measurement of lease liabilities:                                
                                 
Operating cash flows used for operating leases   $ 264,539     $ 375,911     $ 790,159     $ 1,127,733  
Financing cash flows used for financing leases     35,572       52,427       130,732       157,281  
                                 
Assets obtained in exchange for operating lease liabilities     320,732       -       320,732       -  
                                 
Assets obtained in exchange for finance lease liabilities     -       -       4,739       -  
                                 
Weighted average remaining lease term:                                
Operating leases     8.0 years       9 years        8.0 years       9 years  
Finance leases     3.7 years       4.4 years       3.7 years       4.4 years  
                                 
Weighted average discount rate:                                
Operating leases     5.61 %     5.59 %     5.61 %     5.59 %
Finance leases     5.16 %     5.16 %     5.16 %     5.16 %

 

19

 

 

The future minimum lease payments required under operating and financing lease obligations as of September 30, 2022 having initial or remaining non-cancelable lease terms in excess of one year are summarized as follows:

 

    Operating Leases     Finance Leases     Total  
                   
Remainder of 2022   $ 264,540     $ 34,770     $ 299,310  
2023     1,049,351       139,080       1,188,431  
2024     955,272       139,080       1,094,352  
2025     870,000       139,080       1,009,080  
2026     870,000       68,395       938,395  
Thereafter     3,552,500       -       3,552,500  
                         
Total undiscounted lease liabilities     7,561,663       520,405       8,082,068  
Less: imputed interest     (1,454,613 )     (48,077 )     (1,502,690 )
                         
Net lease liabilities   $ 6,107,050     $ 472,328     $ 6,579,378  

 

As of September 30, 2022, the Company does not have additional operating and finance leases that have not yet commenced.

 

NOTE 8 - NOTES PAYABLE AND LOAN FACILITY

 

Letter of Credit

 

The Company entered into a $125,000 letter of credit agreement with Fidelity Co-operative Bank in November 2020. The pledged collateral of a $125,000 cash deposit account is included in prepaid expenses and other. The letter of credit was required pursuant to an agreement with a third-party financial institution for customer financing.

 

Advances

 

On May 29, 2020, Rotmans entered into a sale promotion consulting agreement with a national furniture sales event company. Under the agreement, Rotmans appointed the third-party as its exclusive agent to assist with a high-impact sale. Before the sale, the agent advanced the Company funds of approximately $2,300,000 to pay off a bank line of credit and certain other vendors. The agent will be reimbursed for the advance from the proceeds of the sale. The initial sales agreement with the agent ended in May 2021. A new agreement was entered into with the agent in June 2021. The remaining inventories on hand were used to pay off the liability of the first sale and then simultaneously purchased back for the next sale. The agreement has been amended numerous times and will end in October 2022 as disclosed in Note 18. The agent has a senior first priority security interest and lien in Rotmans inventories and other assets until all obligations and liabilities are satisfied. The outstanding balance of the advance is approximately $1,947,000 and $2,082,000 as of September 30, 2022 and December 31, 2021, respectively, and is included in accounts payable in the accompanying condensed consolidated balance sheet.

 

Term Notes

 

On April 16, 2020, Rotmans received $1,402,900 in loan funding from the Paycheck Protection Program (the “PPP”), established pursuant to the recently enacted Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) and administered by the U.S. Small Business Administration (“SBA”). The unsecured loan (the “PPP Loan”) was evidenced by a promissory note of the Company dated April 16, 2020 (the “Note”) in the principal amount of $1,402,900 with United Community Bank (the “Bank”), the lender. Under the terms of the Note and the PPP Loan, interest accrues on the outstanding principal at the rate of 1.0% per annum. The term of the Note was two years, though it may be payable sooner in connection with an event of default under the Note. On January 24, 2021, the PPP loan was fully forgiven by the SBA.

 

On February 2, 2021, Rotmans received an additional $1,402,900 in PPP loan funding from the SBA. The terms of the Note were the same as the original PPP Loan. On June 25, 2021, the PPP loan was fully forgiven by the SBA.

 

20

 

 

Shareholder, Convertible and Contingently Convertible Notes Payable

 

The following table summarizes shareholder, convertible and contingently convertible notes payable:

                 
    September 30,     December 31,  
    2022     2021  
             
Shareholder, convertible and contingently convertible notes   $ 309,500     $ 1,241,895  
Accrued interest     22,748       147,009  
               
Total shareholder notes and accrued interest     332,248       1,388,904  
Less: current maturities     (332,248 )     (1,388,904 )
                 
Total long-term debt   $ -     $ -  

 

Shareholder Convertible Notes Payable

 

During the year ended December 31, 2018, the Company issued shareholder contingently convertible notes payable, some of which were for contract work performed by other entities in lieu of compensation and expense reimbursement, totaling approximately $335,000. The notes are (i) unsecured, (ii) bear interest at an annual rate of five percent (5%) from date of issuance, and (iii) are convertible at the Company’s option post April 19, 2018. The notes mature one year from issuance but may be extended one (1) additional year by the Company. If converted, the notes plus accrued interest are convertible into shares of the Company’s common stock at the prior twenty (20) day average closing price with a 50% discount. The outstanding balance of all of these notes as of September 30, 2022 and December 31, 2021 is $19,500 and $338,195, respectively. The notes matured in January 2020 and continue to accrue interest until settlement. The unpaid balance on the notes bears interest at an annual rate of eight percent (8%) in arrears. All of these notes except one were settled in April 2022 at a gain of approximately $98,000. The Company issued 53,822 shares of its preferred stock series B in July to complete the settlement.

 

During the year ended December 31, 2019, the Company issued certain contingently convertible promissory notes in varying amounts to existing shareholders which totaled $613,700. The face amount of the note represents the amount due at maturity along with the accrued interest at an annual rate of five percent (5%). The amount can be converted into shares of the Company’s stock, at the option of the Company, based on the average closing price for the trailing 20 days prior to conversion and carrying a 35% to 50% discount. These notes can be converted only after an acceleration event which involves a symbol change, uplisting, or reverse stock split and such conversion is in the control of the Company. All of these notes were settled in April 2022 at a gain of approximately $142,000. The Company issued 98,933 shares of its preferred stock series B in July to complete the settlement.

 

During the year ended December 31, 2021, the Company issued certain contingently convertible promissory notes in varying amounts to existing shareholders which totaled $290,000. The notes are unsecured and bear interest at an annual rate of five percent (5%) from date of issuance. The face amount of the notes represents the amount due at maturity along with the accrued interest. In the event that the spin-off of RxAir does not occur within 2023, the Company will convert these notes into common stock at a conversion price of $1.60. If the spin-off does occur, these notes will convert into RxAir common stock with two conversion prices of $0.15 and $2, which equates to a blended conversion price of $0.18. All of these notes are outstanding as of September 30, 2022. At the issuance date of these notes, it was determined they contain a beneficial conversion feature amounting to approximately $90,000. As these notes are contingently convertible, the beneficial conversion feature will not be recorded on the consolidated financial statements until the actual conversion occurs.

 

Based on the variable conversion price of these notes issued prior to 2021, the Company recorded the embedded conversion features as derivative liabilities, which amounted to $647,100 at December 31, 2021. With the debt settlements beginning in April 2022, the value of the embedded conversion features on the one remaining note was $17,800 at September 30, 2022.

 

21

 

 

Related Party Debt

 

The following table summarizes related party debt:

 

                 
    September 30,     December 31,  
    2022     2021  
             
Rotman Family convertible notes   $ 5,000     $ 1,967,737  
Rotman Family nonconvertible notes     577,500       1,953,509  
Accrued interest     33,525       384,238  
Debt discount     -       (27,083 )
                 
Long term debt, current     616,025       4,278,401  
Less: current maturities     (616,025 )     (1,487,000 )
                 
Long term debt   $ -     $ 2,791,401  

 

Rotman Family Convertible Notes

 

On September 30, 2019, the Company issued contingently convertible promissory notes totaling $180,000 to Steven Rotman ($105,000) and Greg Rotman ($75,000). These notes are (i) unsecured, (ii) bear interest at an annual rate of eight percent (8%) from date of issuance, (iii) are convertible at the Company’s option after December 31, 2019, and (iv) mature five years from issuance. If converted, the notes plus accrued interest are convertible into shares of the Company’s common stock at the average of the five lowest closing prices in the 90-day period prior to conversion with a 50% discount. These notes were settled by the Company in July 2022 with the issuance of 48,276 and 25,812 shares of preferred stock series C to Steven and Greg Rotman, respectively. The balance of the notes payable including accrued interest to Steven and Greg Rotman is approximately $126,000 and $66,000, respectively, at December 31, 2021.

 

On July 18, 2019, the Company issued contingently convertible notes totaling $1,522,500 to Steven Rotman ($1,102,500) and Bernard Rotman ($420,000) as partial consideration for the acquisition of 58% of Rotmans. These notes are (i) unsecured, and (ii) bear interest at an annual rate of five percent (5%) from date of issuance. These notes can be converted only after an acceleration event which involves a symbol change, or reverse stock split and such conversion is in the control of the Company. Steven Rotman’s note matures eight years from issuance and Bernard Rotman’s note matures four years from issuance. If converted, the notes plus accrued interest are convertible into shares of the Company’s common stock at a 20-day average closing price at a 50% discount. These notes were settled by the Company in July 2022 with the issuance of 474,336 and 180,699 shares of preferred stock series C to Steven and Bernard Rotman, respectively. The balance of the notes payable including accrued interest to Steven and Bernard Rotman were approximately $1,238,000 and $472,000, respectively, at December 31, 2021.

 

On December 19, 2019, the Company issued a contingently convertible promissory note totaling $100,000 to Steven Rotman. The face amount of the note represents the amount due at maturity along with the accrued interest at 5%. The amount can be converted into shares of the Company’s stock, at the option of the Company, based on the average closing price for the trailing 20 days prior to conversion and carrying 50% discount. The note can be converted only after an acceleration event which involves a symbol change, uplisting, or reverse stock split and such conversion is in the control of the Company. The note was extended to mature two years from issuance. This note was settled by the Company in July 2022 with the issuance of 42,225 shares of preferred stock series C. The balance of the note payable including accrued interest to Steven Rotman is approximately $110,000 at December 31, 2021, respectively.

 

On February 20, 2020, the Company issued a contingently convertible promissory note totaling $50,000 to Steven Rotman. The face amount of the note represents the amount due at maturity along with the accrued interest at 5%. The amount can be converted into shares of the Company’s stock, at the option of the Company, based on the average closing price for the trailing 20 days prior to conversion and carrying 50% discount. The note can be converted only after an acceleration event which involves a symbol change, uplisting, or reverse stock split and such conversion is in the control of the Company. The note matures two years from issuance. This note was settled by the Company in July 2022 with the issuance of 20,913 shares of preferred stock series C. The balance of the note payable including accrued interest to Steven Rotman is approximately $55,000 at December 31, 2021.

 

22

 

 

On June 3, 2021, the Company issued a contingently convertible promissory note totaling $130,030 to Gregory Rotman. The face amount of the note represents the amount due at maturity along with the accrued interest at 5%. The amount can be converted into shares of the Company’s stock, at the holder’s option, based on the average closing price for the trailing 20 days prior to conversion and carrying 50% discount or $1.65 per share whichever is lower. The holder may elect to accelerate conversion in the event of a spin-out or reverse split. The note matures two years from issuance. This note was settled by the Company in July 2022 with the issuance of 51,896 shares of preferred stock series C. The balance of the note payable including accrued interest to Gregory Rotman is approximately $134,000 December 31, 2021.

 

On August 17, 2021, the Company issued a contingently convertible promissory note totaling $5,000 to Jamie Rotman. The note is unsecured and bears interest at an annual rate of five percent (5%) from date of issuance. The face amount of the note represents the amount due at maturity along with the accrued interest. In the event that the spin-off of RxAir does not occur within 2023, the Company will convert the note into common stock at a conversion price of $1.60. If the spin-off does occur, the note will convert into RxAir common stock with two conversion prices of $0.15 and $2, which equates to a blended conversion price of $0.18. At the issuance date of this note, it was determined to contain a beneficial conversion feature amounting to approximately $2,000. As this note is contingently convertible, the beneficial conversion feature will not be recorded on the consolidated financial statements until the actual conversion occurs. The balance of the note payable including accrued interest to Jamie Rotman is approximately $5,000 at September 30, 2022 and December 31, 2021.

 

The following table summarizes the Rotman Family Convertible Notes:

 

                             
              Carrying Amount  
        Principal     September 30,     December 31,  
    Issue Date   Amount     2022     2021  
Steven Rotman 8.00% note due July 2024   07/18/19   $ 105,000     $ -     $ 126,000  
Gregory Rotman 8.00% note due July 2024   07/18/19     55,207       -       66,264  
Steven Rotman 5.00% note due July 2027   07/18/19     1,102,500       -       1,238,016  
Bernard Rotman 5.00% note due July 2023   07/18/19     420,000       -       471,625  
Steven Rotman 5.00% note due December 2021   12/19/19     100,000       -       110,208  
Steven Rotman 5.00% note due February 2022   02/02/20     50,000       -       54,583  
Gregory Rotman 5.00% note due June 2023   06/03/21     130,030       -       133,822  
Jamie Rotman 5.00% note due August 2022   08/17/21     5,000       5,250       5,094  
                             
 Debt instrument, carrying amount       $ 1,967,737       5,250       2,205,612  
                             
Debt Discount                 -       (27,083 )
                             
 Notes payable               $ 5,250     $ 2,178,529  

 

Based on the variable conversion price for these convertible notes excluding the one issued in August 2021, the Company recorded the embedded conversion features as derivative liabilities, which amounted to $1,131,000 at December 31, 2021. With the subsequent conversions in July 2022, there was no value of the embedded conversion features at September 30, 2022.

 

Rotman Family Nonconvertible Notes

 

In connection with the acquisition of 58% of Rotmans, Steven and Bernard Rotman were issued related party notes payable in the amounts of $367,500 and $140,000, respectively. The notes bear interest at an annual rate of five percent (5%). Steven Rotman’s note matures eight years from issuance and Bernard Rotman’s note matures four years from issuance. Payments of $3,828 and $2,917 to Steven and Bernard Rotman, respectively, per month were scheduled to begin six months from issuance until maturity in December 2027 and 2023, respectively. Steven Rotman’s note was settled by the Company in July with the issuance of 158,112 shares of preferred stock series C. The balance of Bernard Rotman’s note including accrued interest is approximately $162,000 at September 30, 2022. The balance of these notes payable including accrued interest to Steven and Bernard Rotman is approximately $413,000 and $157,000, respectively, at December 31, 2021.

 

23

 

 

During the six months ended December 31, 2020, Steven Rotman advanced the Company funds totaling $1,048,000. In December 2020, the Company formalized the advances and issued a promissory note to Steven Rotman. The note bears interest at an annual rate of five percent (5%) and was due one year from issuance. The maturity date has been extended to December 2022. The face amount of the note represents the amount due at maturity along with accrued interest. This note was settled by the Company in July 2022 with the issuance of 427,296 shares of preferred stock series C. The balance of the note payable including accrued interest to Steven Rotman is approximately $1,115,000, at December 31, 2021.

 

During 2021, Steven Rotman advanced the Company funds totaling $398,009. The Company formalized the advances and issued promissory notes to Steven Rotman. The notes bear interest at an annual rate of five percent (5%) and are due no later than two years from the issuance date. The face amount of the notes represents the amount due at maturity along with accrued interest. These notes were settled by the Company in July 2022 with the issuance of 158,908 shares of preferred stock series C. The balance of the notes payable including accrued interest to Steven Rotman is approximately $415,000 at December 31, 2021.

 

In April 2022, Blue Oar Consulting, Inc. (“Blue Oar”), an entity wholly owned by Gregory Rotman, advanced the Company $500,000 and paid bills totaling $100,000 on the Company’s behalf. The Company formalized the advances and issued a promissory note to Blue Oar. The note bears interest at an annual rate of six percent (6%) and requires weekly payments of $12,500 until the note and interest is paid in full. The Company also granted Blue Oar a security interest in Murida’s inventory.

 

The following table summarizes the Rotman Family Nonconvertible Notes:

                             
              Carrying Amount  
        Principal     September 30,     December 31,  
    Issue Date   Amount     2022     2021  
Steven Rotman 5.00% note due July 2027   07/18/19   $ 367,500     $ -     $ 412,672  
Bernard Rotman 5.00% note due July 2023   07/18/19     140,000       162,458       157,208  
Steven Rotman 5.00% note due December 2022   12/22/20     1,048,000       -       1,115,243  
Steven Rotman 5.00% note due March 2023   03/31/21     395,000       -       411,652  
Steven Rotman 5.00% note due June 2023   06/02/21     3,009       -       3,097  
Blue Oar 6.00% note due May 2023   04/28/22     600,000       448,317       -  
                             
      $ 2,553,509     $ 610,775     $ 2,099,872  

 

Approximate maturities for the succeeding years are as follows:

 

         
Remainder of 2022   $ 345,000  
2023     271,025  
         
 Long term debt   $ 616,025  

 

24

 

 

NOTE 9 - DERIVATIVE LIABILITIES

 

As of September 30, 2022 and December 31, 2021, the Company had a $17,800 and $1,778,100, respectively, derivative liability balance on the condensed consolidated balance sheet and recorded a gain from change in fair value of derivative liabilities of $240,300 and $1,760,300 for the three months and nine months ended September 30, 2022, respectively. The derivative liability activity comes from the convertible notes payable. The Company analyzed the conversion features and warrants of the various note agreements for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion features should be classified as a derivative because the exercise price of these Convertible notes are subject to a variable conversion rate. The Company has determined that the conversion feature is not considered to be solely indexed to the Company’s own stock and is therefore not afforded equity treatment. In accordance with ASC 815, the Company has bifurcated the conversion feature of the notes and recorded a derivative liability.

 

The embedded derivatives for the notes are carried on the Company’s condensed consolidated balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the condensed consolidated statement of operations and the associated fair value carrying amount on the consolidated balance sheet is adjusted by the change. The Company fair values the embedded derivative using a lattice-based valuation model or Monte Carlo simulation. With the settlement of all except one of the convertible notes payable, the balance has been significantly reduced as of September 30, 2022.

 

The following table summarizes the derivative liabilities included in the condensed consolidated balance sheet at September 30, 2022 and December 31, 2021:

 

Fair Value of Embedded Derivative Liabilities:

                 
    2022     2021  
             
Balance, beginning of the period   $ 1,778,100     $ 1,766,700  
                 
Initial measurement of liabilities     -       65,000  
                 
Change in fair value     (1,760,300 )     (53,600 )
                 
Balance, end of the period   $ 17,800     $ 1,778,100  

 

NOTE 10 - STOCKHOLDERS’ DEFICIT

 

Cumulative Convertible Preferred Stock

 

Series A Preferred Stock

 

On May 2, 2013, the Company began a private placement offering to sell up to 200,000 shares of the Company’s 10% Series A Cumulative Convertible Preferred Stock. Under the terms of the offering, the Company offered to sell up to 200,000 shares of preferred stock at $10 per share for a value of $2,000,000. The conversion price was lowered to $5.00 per common share for those holders who invested an additional $25,000 or more in the Company’s common stock in the aforementioned September 2014 Private Placement. The preferred shares have full voting rights as if converted and have a fully participating liquidation preference.

 

As of September 30, 2022, the 8,698 shares of outstanding preferred stock had undeclared dividends of approximately $81,000 and could be converted into 33,607 shares of common stock, at the option of the holder.

 

As of December 31, 2021, the 8,698 shares of outstanding preferred stock had undeclared dividends of approximately $75,000 and could be converted into 32,303 shares of common stock, at the option of the holder.

 

25

 

 

Series B Preferred Stock

 

On April 11, 2022, the Company amended its Articles of Incorporation to add the terms of a 10% Series B Cumulative Convertible Preferred Stock. Under the amendment, the number of shares authorized are 2,500,000. The preferred stock accumulates a 10% per annum dividend and is convertible into 10 shares of common stock at the option of the holder. The holders of Series B preferred stock have full voting rights as if converted and have a fully participating liquidation preference.

 

As of September 30, 2022, the 370,969 shares of outstanding preferred stock had undeclared dividends of approximately $43,000 and could be converted into 3,771,519 shares of common stock, at the option of the holder.

 

Series C Preferred Stock

 

On July 8, 2022, the Company amended its Articles of Incorporation to add the terms of a 10% Series C Cumulative Convertible Preferred Stock. Under the amendment, the number of shares authorized are 2,500,000. The preferred stock accumulates a 10% per annum dividend and is convertible into 10 shares of common stock at the option of the holder. The holders of Series C preferred stock have full voting rights as if converted and have a fully participating liquidation preference.

 

As of September 30, 2022, the 1,917,973 shares of outstanding preferred stock had undeclared dividends of approximately $75,000 and could be converted into 19,466,562 shares of common stock, at the option of the holder.

 

Common Stock and Warrants

 

During the nine months ended September 30, 2022, the Company retired 200 shares of previously issued common stock. Included in stock subscription payable at September 30, 2022, is $270,000 received under common stock subscription agreements for 180,000 shares during the year ended December 31, 2020.

 

Stock Subscription Payable

 

At September 30, 2022 and December 31, 2021, the Company recorded $1,539,600 and $1,247,549, respectively, of stock subscription payable related to common stock to be issued. The following summarizes the activity of stock subscription payable during the period ended September 30, 2022 and December 31, 2021:

 

    Amount     Shares  
             
Balance, January 1, 2021   $ 2,589,556       994,314  
Additions, net     806,082       421,854  
Issuances, net     (2,148,089 )     (811,110 )
                 
Balance, December 31, 2021     1,247,549       605,058  
Additions, net     544,039       828,281  
Issuances, net     (251,988 )     (25,568 )
                 
Balance, September 30, 2022   $ 1,539,600       1,407,771  

 

26

 

 

NOTE 11 - REVENUES

 

The following table presents our revenues disaggregated by each major product category and service for the three and nine months ended September 30, 2022 and 2021:

SCHEDULE OF REVENUES

                                                                 
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2022     2021     2022     2021  
          % of           % of           % of           % of  
    Net Sales     Net Sales     Net Sales     Net Sales     Net Sales     Net Sales     Net Sales     Net Sales  
Merchandise:                                                                
Case Goods                                                                
Bedroom Furniture   $ 481,765       13.5     $ 398,807       9.8     $ 1,167,928       11.0     $ 1,725,588       7.5  
Dining Room Furniture     260,123       7.3       235,945       5.8       641,042       6.0       1,337,503       5.8  
Occasional     327,709       9.2       422,044